Multimeric-001 Universal Flu Vaccine: Preliminary Phase II data

Preliminary data from the double-blind, placebo-controlled, Israeli Phase II BVX-006 trial in 36 volunteers ages 50-65 showed that 3 intramuscular injections of 1 mg M-001 every 21 days followed by an...